Having high blood pressure or being hypertensive would entail a lot of changes in your lifestyle if you want to avoid the health complications that it could lead to.
You are said to be suffering high blood pressure when the force of your blood pushing against the walls of your blood vessels is consistently too high.
If not regulated, high blood pressure can cause harm to your heart and blood vessels because it can make these two work harder and less efficiently.
If untreated, the force and friction of high blood pressure will damage the delicate tissues inside the arteries.
As earlier said, once you become hypertensive, you have to be very careful, which means a lifestyle change.
Your diet will play a big part as you have to avoid food high in cholesterol, food with high sugar content as well as food that are high in sodium or salt content.
Aside from the food, you also have to watch over what you drink. Same as food, you have to avoid sugary drinks as well as alcohol.
There are, however, food and drinks that you can swap that can help lower and keep your high blood pressure in check.
Coconut water, which in recent years, have become popular, is one drink that, according to study, can help lower high blood pressure.
The drink is rich in potassium, vitamin C, and magnesium. In fact, a 240ml of coconut water contains 600mg of potassium. Potassium is said to be responsible for lowering high blood pressure.
A study had shown that coconut water had improved the high blood pressure readings of 71 percent of its participants.
The coconut has always been known to be highly nutritious and has a lot of health benefits.
Aside from lowering high blood pressure, coconut water could also help in reducing high cholesterol. Studies also found coconut water to fight against diabetes.
Coconut water is a refreshing drink, so it will be easy to swap your favorite sugary drinks with it.
Not only will you be keeping your blood pressure in check, but you will also be able to lower your risk for other life-threatening conditions.
Image credit courtesy of Phu Thinh Co/Flickr


Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 



